Our core business is the commercialization of prescription medicines that can help millions of patients.
Zylera has a diversified portfolio of products prescribed by pediatricians and women’s health clinicians to treat various conditions.
POLY-VI-FLOR® multivitamin with sodium fluoride supplement helps prevent dental cavities.
Research Triangle Park, NC, November 15, 2011 — Zylera Pharmaceuticals, LLC, a specialty pharmaceutical company that develops, acquires and commercializes prescription pharmaceutical products and dietary supplements and markets those products in the U.S. is pleased to announce the appointment of Matthew V. Phillips as Chief Operating Officer. Prior to joining Zylera Matt was Executive Director…
read more...
BioTech news Sales & Marketing